Sanofi-aventis (Thailand) Co., Ltd.
87/2 CRC Tower, 24th Fl., All Seasons Place, Wireless Rd., Lumpini, Pathumwan, Bangkok 10330 Thailand
Tel: +66 (0) 2 264 9999
Fax: +66 (0) 2 264 9998
E-mail: [email protected]
Website: http://www.sanofi.co.th

Industry/Activities:
Pharmaceutical and consumer healthcare

Company Profile:

Sanofi-aventis Thailand is part of Sanofi, a global integrated healthcare leader, focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi has its roots in Thailand since 1959 when Hoechst registered, and became Sanofi in 2005. Sanofi Group is present through 4 entities: Sanofi, Sanofi Pasteur, Merial, and the GPO-MBP Ltd (Government Pharmaceutical Organization- Merieux Biological Product), a joint venture between GPO (49%), Sanofi Pasteur (49%) and Crown Property Bureau (2%).

Products & Services:

Our local presence includes

•  Pharmaceutical market: Provide leading therapeutic solution for cardiovascular, thrombosis, diabetes, oncology, internal medicine and central nervous system
•  Growing Consumer Healthcare Division led by the feminine hygiene wash Lactacyd
• And a footprint in rare diseases such as Genetic Lysosomal Storage Disorders (Gaucher, Pompe, MPS and Fabry)

Senior Management:

1. Cem Ozturk, Thailand and Myanmar Country Chair, General Management

2. Jérôme Lucien-Joseph Carle, Chief Financial Officer